|
G |
Abca1 |
ATP binding cassette subfamily A member 1 |
increases expression |
EXP |
Monocrotophos results in increased expression of ABCA1 mRNA |
CTD |
PMID:32267039 |
|
NCBI chr 5:67,678,267...67,801,162
Ensembl chr 5:67,681,297...67,801,170
|
|
G |
Acaca |
acetyl-CoA carboxylase alpha |
increases expression increases activity |
EXP |
Monocrotophos results in increased expression of ACACA mRNA Monocrotophos results in increased activity of ACACA protein |
CTD |
PMID:32267039 |
|
NCBI chr10:69,014,261...69,276,453
Ensembl chr10:69,014,170...69,276,457
|
|
G |
Ache |
acetylcholinesterase |
multiple interactions decreases activity decreases expression |
ISO EXP |
asoxime chloride inhibits the reaction [Monocrotophos results in decreased activity of ACHE protein]; HLo 7 inhibits the reaction [Monocrotophos results in decreased activity of ACHE protein]; Obidoxime Chloride inhibits the reaction [Monocrotophos results in decreased activity of ACHE protein]; pralidoxime inhibits the reaction [Monocrotophos results in decreased activity of ACHE protein] [Dichlorvos co-treated with Monocrotophos] results in increased activity of ACHE protein; [Monocrotophos co-treated with Dichlorvos] results in decreased activity of ACHE protein; [sodium arsenite co-treated with Dichlorvos co-treated with Monocrotophos] results in decreased activity of ACHE protein Monocrotophos results in decreased expression of ACHE mRNA |
CTD |
PMID:8783813 PMID:15679473 PMID:15793557 PMID:19730754 PMID:20026515 PMID:20728503 PMID:21349312 PMID:22285544 PMID:22903060 More...
|
|
NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
decreases expression |
EXP |
Monocrotophos results in decreased expression of ADIPOQ protein |
CTD |
PMID:32267039 |
|
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
|
|
G |
Ahr |
aryl hydrocarbon receptor |
affects expression multiple interactions increases expression |
ISO |
Monocrotophos affects the expression of AHR protein [Monocrotophos co-treated with Cimetidine] results in increased expression of AHR protein; [Rifampin co-treated with Monocrotophos] results in decreased expression of AHR mRNA; [Rifampin co-treated with Monocrotophos] results in increased expression of AHR protein Monocrotophos results in increased expression of AHR mRNA |
CTD |
PMID:22733800 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Aifm1 |
apoptosis inducing factor, mitochondria associated 1 |
multiple interactions decreases expression |
ISO |
Monocrotophos promotes the reaction [AIFM1 protein binds to NFE2L2 protein] Monocrotophos results in decreased expression of AIFM1 protein |
CTD |
PMID:33078895 |
|
NCBI chr X:127,650,223...127,689,356
Ensembl chr X:127,650,226...127,689,256
|
|
G |
Apex1 |
apurinic/apyrimidinic endodeoxyribonuclease 1 |
multiple interactions increases expression |
ISO |
Monocrotophos results in increased expression of and affects the localization of APEX1 protein Monocrotophos results in increased expression of APEX1 mRNA |
CTD |
PMID:28887667 |
|
NCBI chr15:24,144,595...24,146,785
Ensembl chr15:24,144,362...24,146,785
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions increases expression |
EXP |
Monocrotophos results in increased expression of and affects the localization of BAX protein; resveratrol inhibits the reaction [Monocrotophos results in increased expression of BAX mRNA]; resveratrol inhibits the reaction [Monocrotophos results in increased expression of BAX protein] Monocrotophos results in increased expression of BAX mRNA; Monocrotophos results in increased expression of BAX protein |
CTD |
PMID:20957986 PMID:21445290 PMID:23833438 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bbc3 |
Bcl-2 binding component 3 |
increases expression |
EXP |
Monocrotophos results in increased expression of BBC3 mRNA |
CTD |
PMID:20957986 |
|
NCBI chr 1:77,013,281...77,022,509
Ensembl chr 1:77,014,543...77,022,509
|
|
G |
Bche |
butyrylcholinesterase |
decreases activity |
EXP |
Monocrotophos results in decreased activity of BCHE protein |
CTD |
PMID:19730754 |
|
NCBI chr 2:158,308,674...158,401,148
Ensembl chr 2:158,307,584...158,401,148
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
increases expression decreases expression multiple interactions |
EXP |
Monocrotophos results in increased expression of BCL2 mRNA; Monocrotophos results in increased expression of BCL2 protein Monocrotophos results in decreased expression of BCL2 mRNA; Monocrotophos results in decreased expression of BCL2 protein resveratrol inhibits the reaction [Monocrotophos results in decreased expression of BCL2 mRNA]; resveratrol inhibits the reaction [Monocrotophos results in decreased expression of BCL2 protein] |
CTD |
PMID:20957986 PMID:21445290 PMID:23833438 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bcl2l2 |
Bcl2-like 2 |
decreases expression |
EXP |
Monocrotophos results in decreased expression of BCL2L2 mRNA; Monocrotophos results in decreased expression of BCL2L2 protein |
CTD |
PMID:20957986 PMID:21445290 |
|
NCBI chr15:28,346,449...28,361,627
Ensembl chr15:28,356,807...28,361,624
|
|
G |
Casp3 |
caspase 3 |
increases expression multiple interactions |
EXP |
Monocrotophos results in increased expression of CASP3 mRNA; Monocrotophos results in increased expression of CASP3 protein; Monocrotophos results in increased expression of CASP3 protein modified form resveratrol inhibits the reaction [Monocrotophos results in increased expression of CASP3 mRNA]; resveratrol inhibits the reaction [Monocrotophos results in increased expression of CASP3 protein] |
CTD |
PMID:20957986 PMID:21445290 PMID:23833438 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp9 |
caspase 9 |
increases expression |
EXP |
Monocrotophos results in increased expression of CASP9 mRNA; Monocrotophos results in increased expression of CASP9 protein; Monocrotophos results in increased expression of CASP9 protein modified form |
CTD |
PMID:20957986 PMID:21445290 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
decreases activity |
EXP |
Monocrotophos results in decreased activity of CAT protein |
CTD |
PMID:22751200 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
increases expression |
EXP |
Monocrotophos results in increased expression of CDKN1A mRNA; Monocrotophos results in increased expression of CDKN1A protein |
CTD |
PMID:20957986 PMID:21445290 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cox4i1 |
cytochrome c oxidase subunit 4i1 |
multiple interactions decreases expression |
EXP |
Acetylcysteine inhibits the reaction [Monocrotophos results in decreased expression of COX4I1 mRNA] |
CTD |
PMID:35403558 |
|
NCBI chr19:48,721,680...48,727,920
Ensembl chr19:48,721,199...48,727,921
|
|
G |
Cycs |
cytochrome c, somatic |
multiple interactions |
EXP |
Monocrotophos results in increased expression of and affects the localization of CYCS protein |
CTD |
PMID:20957986 |
|
NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
increases expression increases activity multiple interactions |
EXP ISO |
Monocrotophos results in increased expression of CYP1A1 protein Monocrotophos results in increased activity of CYP1A1 protein Monocrotophos results in increased expression of CYP1A1 mRNA; Monocrotophos results in increased expression of CYP1A1 protein [Monocrotophos co-treated with Cimetidine] results in increased expression of CYP1A1 protein; [Rifampin co-treated with Monocrotophos] results in increased activity of CYP1A1 protein; [Rifampin co-treated with Monocrotophos] results in increased expression of CYP1A1 mRNA; [Rifampin co-treated with Monocrotophos] results in increased expression of CYP1A1 protein |
CTD |
PMID:21445290 PMID:22733800 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
increases expression |
EXP |
Monocrotophos results in increased expression of CYP1A2 protein |
CTD |
PMID:21445290 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
increases expression |
EXP |
Monocrotophos results in increased expression of CYP2B2 protein |
CTD |
PMID:21445290 |
|
NCBI chr 1:81,594,534...81,608,567
Ensembl chr 1:81,594,555...81,608,566
|
|
G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
increases activity multiple interactions increases expression |
ISO |
Monocrotophos results in increased activity of CYP2B6 protein [Monocrotophos co-treated with Cimetidine] results in increased expression of CYP2B6 protein; [Rifampin co-treated with Monocrotophos] results in increased activity of CYP2B6 protein; [Rifampin co-treated with Monocrotophos] results in increased expression of CYP2B6 mRNA; [Rifampin co-treated with Monocrotophos] results in increased expression of CYP2B6 protein Monocrotophos results in increased expression of CYP2B6 mRNA; Monocrotophos results in increased expression of CYP2B6 protein |
CTD |
PMID:22733800 |
|
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
increases expression increases activity multiple interactions |
EXP ISO |
Monocrotophos results in increased expression of CYP2E1 protein Monocrotophos results in increased activity of CYP2E1 protein Monocrotophos results in increased expression of CYP2E1 mRNA; Monocrotophos results in increased expression of CYP2E1 protein [Monocrotophos co-treated with Cimetidine] results in increased expression of CYP2E1 protein; [Rifampin co-treated with Monocrotophos] results in increased activity of CYP2E1 protein; [Rifampin co-treated with Monocrotophos] results in increased expression of CYP2E1 mRNA; [Rifampin co-treated with Monocrotophos] results in increased expression of CYP2E1 protein |
CTD |
PMID:21445290 PMID:22733800 |
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
increases activity increases expression multiple interactions |
ISO |
Monocrotophos results in increased activity of CYP3A4 protein Monocrotophos results in increased expression of CYP3A4 mRNA; Monocrotophos results in increased expression of CYP3A4 protein [Monocrotophos co-treated with Cimetidine] results in increased expression of CYP3A4 protein; [Rifampin co-treated with Monocrotophos] results in increased activity of CYP3A4 protein; [Rifampin co-treated with Monocrotophos] results in increased expression of CYP3A4 mRNA; [Rifampin co-treated with Monocrotophos] results in increased expression of CYP3A4 protein |
CTD |
PMID:22733800 |
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Cyp7a1 |
cytochrome P450 family 7 subfamily A member 1 |
increases expression |
EXP |
Monocrotophos results in increased expression of CYP7A1 mRNA |
CTD |
PMID:32267039 |
|
NCBI chr 5:19,376,979...19,386,676
Ensembl chr 5:19,376,974...19,386,688
|
|
G |
Fasn |
fatty acid synthase |
increases activity increases expression |
EXP |
Monocrotophos results in increased activity of FASN protein Monocrotophos results in increased expression of FASN mRNA |
CTD |
PMID:32267039 |
|
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
increases expression |
EXP |
Monocrotophos results in increased expression of FOS protein |
CTD |
PMID:20957986 PMID:21445290 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
G6pd |
glucose-6-phosphate dehydrogenase |
affects activity multiple interactions increases activity |
EXP |
Monocrotophos affects the activity of G6PD protein [Monocrotophos co-treated with quinalphos] affects the activity of G6PD protein Monocrotophos results in increased activity of G6PD protein |
CTD |
PMID:24248738 PMID:32267039 |
|
NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801
|
|
G |
Gck |
glucokinase |
increases activity |
EXP |
Monocrotophos results in increased activity of GCK protein |
CTD |
PMID:32267039 |
|
NCBI chr14:80,785,060...80,829,842
Ensembl chr14:80,785,060...80,826,995
|
|
G |
Gsr |
glutathione-disulfide reductase |
decreases activity affects activity multiple interactions |
EXP |
Monocrotophos results in decreased activity of GSR protein Monocrotophos affects the activity of GSR protein [Monocrotophos co-treated with quinalphos] affects the activity of GSR protein |
CTD |
PMID:22751200 PMID:24248738 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
increases expression multiple interactions |
EXP ISO |
Monocrotophos results in increased expression of GSTP1 mRNA; Monocrotophos results in increased expression of GSTP1 protein [Monocrotophos co-treated with Cimetidine] results in increased expression of GSTP1 protein; [Rifampin co-treated with Monocrotophos] results in increased expression of GSTP1 mRNA; [Rifampin co-treated with Monocrotophos] results in increased expression of GSTP1 protein |
CTD |
PMID:21445290 PMID:22733800 |
|
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
|
|
G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
increases expression |
EXP |
Monocrotophos results in increased expression of HMGCR mRNA |
CTD |
PMID:32267039 |
|
NCBI chr 2:27,997,523...28,018,983
Ensembl chr 2:27,997,525...28,019,703
|
|
G |
Il2 |
interleukin 2 |
decreases response to substance |
ISO |
Monocrotophos results in decreased susceptibility to IL2 protein |
CTD |
PMID:8349949 |
|
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
increases expression multiple interactions |
EXP ISO |
Monocrotophos results in increased expression of JUN protein Monocrotophos results in increased expression of and results in increased phosphorylation of JUN protein |
CTD |
PMID:20957986 PMID:21445290 PMID:28887667 |
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Ldlr |
low density lipoprotein receptor |
increases expression |
EXP |
Monocrotophos results in increased expression of LDLR mRNA |
CTD |
PMID:32267039 |
|
NCBI chr 8:20,270,020...20,292,981
Ensembl chr 8:20,270,041...20,294,580
|
|
G |
Lig3 |
DNA ligase 3 |
increases expression |
ISO |
Monocrotophos results in increased expression of LIG3 mRNA |
CTD |
PMID:28887667 |
|
NCBI chr10:67,717,808...67,741,141
Ensembl chr10:67,717,812...67,798,414
|
|
G |
Lpin1 |
lipin 1 |
increases activity |
EXP |
Monocrotophos results in increased activity of LPIN1 protein |
CTD |
PMID:32267039 |
|
NCBI chr 6:39,309,198...39,417,034
Ensembl chr 6:39,312,748...39,417,097
|
|
G |
Lpl |
lipoprotein lipase |
increases expression |
EXP |
Monocrotophos results in increased expression of LPL mRNA |
CTD |
PMID:32267039 |
|
NCBI chr16:20,830,055...20,853,855
Ensembl chr16:20,829,465...20,855,249
|
|
G |
Maoa |
monoamine oxidase A |
decreases activity |
EXP |
Monocrotophos results in decreased activity of MAOA protein |
CTD |
PMID:12018584 |
|
NCBI chr X:6,032,172...6,098,308
Ensembl chr X:6,030,795...6,099,593
|
|
G |
Maob |
monoamine oxidase B |
decreases activity |
EXP |
Monocrotophos results in decreased activity of MAOB protein |
CTD |
PMID:12018584 |
|
NCBI chr X:5,907,327...6,010,996
Ensembl chr X:5,907,266...6,011,003
|
|
G |
Mcl1 |
MCL1 apoptosis regulator, BCL2 family member |
decreases expression |
EXP |
Monocrotophos results in decreased expression of MCL1 mRNA; Monocrotophos results in decreased expression of MCL1 protein |
CTD |
PMID:20957986 PMID:21445290 |
|
NCBI chr 2:183,219,137...183,235,676
Ensembl chr 2:183,219,220...183,222,303
|
|
G |
Mt-nd1 |
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1 |
multiple interactions decreases expression |
EXP |
Acetylcysteine inhibits the reaction [Monocrotophos results in decreased expression of ND1 mRNA] |
CTD |
PMID:35403558 |
|
NCBI chr MT:2,740...3,694 NCBI chr MT:2,740...3,694 NCBI chr MT:2,740...3,694 NCBI chr MT:2,740...3,694 NCBI chr MT:2,740...3,694 NCBI chr MT:2,740...3,694 NCBI chr MT:2,740...3,694 NCBI chr MT:2,740...3,694 NCBI chr MT:2,740...3,694
Ensembl chr MT:2,740...3,694
|
|
G |
Mt-nd2 |
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2 |
decreases expression multiple interactions |
EXP |
Monocrotophos results in decreased expression of ND2 mRNA Acetylcysteine inhibits the reaction [Monocrotophos results in decreased expression of ND2 mRNA] |
CTD |
PMID:35403558 |
|
NCBI chr MT:3,904...4,942 NCBI chr MT:3,904...4,942 NCBI chr MT:3,904...4,942 NCBI chr MT:3,904...4,942 NCBI chr MT:3,904...4,942 NCBI chr MT:3,904...4,942 NCBI chr MT:3,904...4,942 NCBI chr MT:3,904...4,942 NCBI chr MT:3,904...4,942
Ensembl chr MT:3,904...4,942
|
|
G |
Nes |
nestin |
decreases expression increases expression |
ISO |
Monocrotophos results in decreased expression of NES mRNA Monocrotophos results in increased expression of NES protein |
CTD |
PMID:33569802 |
|
NCBI chr 2:173,437,867...173,447,777
Ensembl chr 2:173,438,734...173,447,777
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
increases expression multiple interactions decreases expression |
ISO EXP |
Monocrotophos results in increased expression of NFE2L2 protein Monocrotophos promotes the reaction [AIFM1 protein binds to NFE2L2 protein] Monocrotophos results in decreased expression of NFE2L2 mRNA |
CTD |
PMID:28887667 PMID:33078895 PMID:35403558 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
affects expression multiple interactions |
ISO |
Monocrotophos affects the expression of NR1I2 protein [Monocrotophos co-treated with Cimetidine] results in increased expression of NR1I2 protein; [Rifampin co-treated with Monocrotophos] results in increased expression of NR1I2 protein |
CTD |
PMID:22733800 |
|
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
|
|
G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
multiple interactions decreases expression increases expression |
ISO |
[Monocrotophos co-treated with Cimetidine] results in increased expression of NR1I3 protein; [Rifampin co-treated with Monocrotophos] results in increased expression of NR1I3 mRNA; [Rifampin co-treated with Monocrotophos] results in increased expression of NR1I3 protein Monocrotophos results in decreased expression of NR1I3 protein Monocrotophos results in increased expression of NR1I3 mRNA; Monocrotophos results in increased expression of NR1I3 protein |
CTD |
PMID:22733800 |
|
NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906
|
|
G |
Nrf1 |
nuclear respiratory factor 1 |
multiple interactions decreases expression |
EXP |
Acetylcysteine inhibits the reaction [Monocrotophos results in decreased expression of NRF1 mRNA] |
CTD |
PMID:35403558 |
|
NCBI chr 4:58,664,932...58,772,328
Ensembl chr 4:58,664,957...58,825,328
|
|
G |
Ogg1 |
8-oxoguanine DNA glycosylase |
decreases expression |
ISO |
Monocrotophos results in decreased expression of OGG1 mRNA |
CTD |
PMID:28887667 |
|
NCBI chr 4:146,474,701...146,481,959
Ensembl chr 4:146,474,750...146,484,766
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
increases expression |
ISO |
Monocrotophos results in increased expression of PARP1 mRNA; Monocrotophos results in increased expression of PARP1 protein |
CTD |
PMID:28887667 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
decreases expression |
EXP |
Monocrotophos results in decreased expression of PPARA mRNA |
CTD |
PMID:32267039 |
|
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
increases expression |
EXP |
Monocrotophos results in increased expression of PPARG mRNA |
CTD |
PMID:32267039 |
|
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Ppargc1a |
PPARG coactivator 1 alpha |
decreases expression multiple interactions |
EXP |
Monocrotophos results in decreased expression of PPARGC1A mRNA Acetylcysteine inhibits the reaction [Monocrotophos results in decreased expression of PPARGC1A mRNA] |
CTD |
PMID:35403558 |
|
NCBI chr14:58,860,752...59,516,525
Ensembl chr14:58,861,144...59,512,656
|
|
G |
Scarb1 |
scavenger receptor class B, member 1 |
increases expression |
EXP |
Monocrotophos results in increased expression of SCARB1 mRNA |
CTD |
PMID:32267039 |
|
NCBI chr12:31,296,143...31,362,649
Ensembl chr12:31,296,156...31,362,647
|
|
G |
Sod2 |
superoxide dismutase 2 |
decreases expression multiple interactions |
EXP |
Monocrotophos results in decreased expression of SOD2 mRNA Acetylcysteine inhibits the reaction [Monocrotophos results in decreased expression of SOD2 mRNA] |
CTD |
PMID:35403558 |
|
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
|
|
G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
increases expression |
EXP |
Monocrotophos results in increased expression of SREBF1 mRNA |
CTD |
PMID:32267039 |
|
NCBI chr10:45,007,637...45,029,650
Ensembl chr10:45,007,637...45,029,650
|
|
G |
Srebf2 |
sterol regulatory element binding transcription factor 2 |
increases expression |
EXP |
Monocrotophos results in increased expression of SREBF2 mRNA |
CTD |
PMID:32267039 |
|
NCBI chr 7:113,663,202...113,720,850
Ensembl chr 7:113,663,202...113,720,848
|
|
G |
Tac1 |
tachykinin, precursor 1 |
multiple interactions |
ISO |
[perfluorooctanoic acid co-treated with Monocrotophos] results in decreased expression of TAC1 mRNA |
CTD |
PMID:33569802 |
|
NCBI chr 4:35,679,183...35,687,180
Ensembl chr 4:35,679,704...35,687,178
|
|
G |
Tfam |
transcription factor A, mitochondrial |
multiple interactions decreases expression |
EXP |
Acetylcysteine inhibits the reaction [Monocrotophos results in decreased expression of TFAM mRNA] |
CTD |
PMID:35403558 |
|
NCBI chr20:17,356,243...17,368,293
Ensembl chr20:17,356,197...17,368,292
|
|
G |
Th |
tyrosine hydroxylase |
multiple interactions increases activity |
EXP |
Mifepristone inhibits the reaction [Monocrotophos results in increased activity of TH protein] |
CTD |
PMID:22305719 |
|
NCBI chr 1:198,071,500...198,078,832
Ensembl chr 1:198,071,503...198,109,767
|
|
G |
Tnf |
tumor necrosis factor |
increases expression |
EXP |
Monocrotophos results in increased expression of TNF protein |
CTD |
PMID:32267039 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tp53 |
tumor protein p53 |
increases expression |
EXP |
Monocrotophos results in increased expression of TP53 mRNA; Monocrotophos results in increased expression of TP53 protein; Monocrotophos results in increased expression of TRP53 mRNA; Monocrotophos results in increased expression of TRP53 protein |
CTD |
PMID:20957986 PMID:21445290 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|